CXCL12 G801A polymorphism and breast cancer risk: A meta-analysis

Molecular Biology Reports

Volumn 39, Issue 2, 2012, Pages 2039-2044

  Shen, Weisheng ^a   Cao, Xiangming ^a   Xi, Lei ^a   Deng, Lichun ^a  

^a JIANGYIN PEOPLE S HOSPITAL   (China)

Author keywords

Breast cancer; CXCL12; Meta analysis; Molecular epidemiology

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CXCL12 GENE; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENE; GENETIC ANALYSIS; HARDY WEINBERG DISTRIBUTION LAW; HUMAN; META ANALYSIS; SYSTEMATIC REVIEW; BIOLOGICAL MODEL; BREAST TUMOR; FEMALE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; INHERITANCE; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CXCL12 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

BREAST NEOPLASMS; CHEMOKINE CXCL12; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INHERITANCE PATTERNS; MODELS, GENETIC; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84860350399     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-0951-7     Document Type: Article

References (23)

1. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168-183 (Pubitemid 43847927)
2. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K (2000) Environmental and heritable factors in the causation of cancer- analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343:78-85 (Pubitemid 30451850)
3. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-127 (Pubitemid 30398626)
4. Caux C, Ait-Yahia S, Chemin K, de Bouteiller O, Dieu-Nosjean MC, Homey B, Massacrier C, Vanbervliet B, Zlotnik A, Vicari A (2000) Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22:345-369
5. Rossi D, Zlotnik A (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217-242
6. Balkwill F (2003) Chemokine biology in cancer. Semin Immunol 15:49-55 (Pubitemid 36092178)
7. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR (1998) Function of the chemokine receptor CXCR4 in haemat-opoiesis and in cerebellar development. Nature 393:595-599 (Pubitemid 28319251)
8. Olson KE, Booth GC, Poulin F, Sonenberg N, Beretta L (2009) Impaired myelopoiesis in mice lacking the repressors of translation initiation, 4E-BP1 and 4E-BP2. Immunology 128:e376-e384
9. Ben-Baruch A (2003) Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res 5:31-36 (Pubitemid 36553576)
10. Kato M, Kitayama J, Kazama S, Nagawa H (2003) Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma. Breast Cancer Res 5:R144-R150
11. Winkler C, Modi W, Smith MW, Nelson GW, Wu X, Carrington M, Dean M, Honjo T, Tashiro K, Yabe D et al (1998) Genetic restriction of AIDS pathogenesis by an SDF-1 chemokine gene variant. ALIVE Study, Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC). Science 279:389-393
12. Watanabe MA, de Oliveira Cavassin GG, Orellana MD, Milanezi CM, Voltarelli JC, Kashima S, Covas DT (2003) SDF-1 gene polymorphisms and syncytia induction in Brazilian HIV-1 infected individuals. Microb Pathog 35:31-34 (Pubitemid 36809187)
13. Handoll HH (2006) Systematic reviews on rehabilitation interventions. Arch Phys Med Rehabil 87:875 (Pubitemid 43767714)
14. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
15. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
16. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634 (Pubitemid 27387172)
17. Zafiropoulos A, Crikas N, Passam AM, Spandidos DA (2004) Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41:e59
18. Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A (2005) Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer Lett 225:261-266 (Pubitemid 40835873)
19. de Oliveira KB, Oda JM, Voltarelli JC, Nasser TF, Ono MA, Fujita TC, Matsuo T, Watanabe MA (2009) CXCL12 rs1801157 polymorphism in patients with breast cancer, Hodgkin's lymphoma, and non-Hodgkin's lymphoma. J Clin Lab Anal 23:387-393
20. Lin GT, Tseng HF, Yang CH, Hou MF, Chuang LY, Tai HT, Tai MH, Cheng YH, Wen CH, Liu CS et al (2009) Combinational polymorphisms of seven CXCL12-related genes are protective against breast cancer in Taiwan. OMICS 13:165-172
21. 0 G801A polymorphism is not a risk factor for breast cancer. DNA Cell Biol 29:423-427
22. Hassan S, Baccarelli A, Salvucci O, Basik M (2008) Plasma stromal cell-derived factor-1: host derived marker predictive of distant metastasis in breast cancer. Clin Cancer Res 14:446-454 (Pubitemid 351226112)
23. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61 (Pubitemid 44698579)